44.67
0.79%
0.35
Dopo l'orario di chiusura:
44.67
Precedente Chiudi:
$44.32
Aprire:
$43.84
Volume 24 ore:
1.32M
Relative Volume:
1.43
Capitalizzazione di mercato:
$9.93B
Reddito:
$1.97B
Utile/perdita netta:
$92.93M
Rapporto P/E:
30.81
EPS:
1.45
Flusso di cassa netto:
$459.60M
1 W Prestazione:
-1.61%
1M Prestazione:
+6.13%
6M Prestazione:
+6.64%
1 anno Prestazione:
+3.06%
Qiagen Nv Stock (QGEN) Company Profile
Nome
Qiagen Nv
Settore
Industria
Telefono
-
Indirizzo
-
Confronta QGEN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.67 | 9.93B | 1.97B | 92.93M | 459.60M | 0.4066 |
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-10 | Aggiornamento | Jefferies | Hold → Buy |
2024-10-17 | Downgrade | HSBC Securities | Buy → Hold |
2024-06-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
2023-12-07 | Aggiornamento | Goldman | Neutral → Buy |
2023-09-12 | Iniziato | Robert W. Baird | Outperform |
2023-05-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
2022-01-18 | Aggiornamento | DZ Bank | Hold → Buy |
2021-10-15 | Ripresa | Cowen | Market Perform |
2021-10-14 | Iniziato | Redburn | Buy |
2021-07-14 | Downgrade | Kepler | Buy → Hold |
2021-06-03 | Iniziato | Goldman | Neutral |
2020-10-06 | Ripresa | BofA Securities | Buy |
2020-09-28 | Aggiornamento | Kepler | Hold → Buy |
2020-08-24 | Aggiornamento | Citigroup | Neutral → Buy |
2020-08-20 | Ripresa | JP Morgan | Overweight |
2020-08-17 | Aggiornamento | Berenberg | Hold → Buy |
2020-08-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
2020-08-14 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
2020-03-04 | Downgrade | Berenberg | Buy → Hold |
2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
2020-01-07 | Iniziato | Citigroup | Neutral |
2019-12-26 | Ripresa | BofA/Merrill | Underperform |
2019-11-15 | Iniziato | Stifel | Hold |
2019-11-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-11-14 | Aggiornamento | JP Morgan | Underweight → Overweight |
2019-11-14 | Aggiornamento | Kepler | Reduce → Hold |
2019-10-17 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2019-10-09 | Downgrade | Kepler | Hold → Reduce |
2019-10-08 | Downgrade | Barclays | Overweight → Equal Weight |
2019-10-08 | Downgrade | Deutsche Bank | Buy → Hold |
2019-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Qiagen Nv Borsa (QGEN) Ultime notizie
August 2025 Options Now Available For Qiagen (QGEN) - Nasdaq
Qiagen Announces AFM Notification on BlackRock Shareholding - TipRanks
Qiagen Highlights BlackRock’s Indirect Stake in Voting Rights Disclosure - TipRanks
State Street Corp Boosts Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret - MSN
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
QIAGEN Launches Ingenuity Pathway Analysis Interpret - Marketscreener.com
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data - Business Wire
Public Employees Retirement System of Ohio Buys Shares of 214,400 Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Barclays PLC - MarketBeat
QIAGEN Unveils AI-Powered IPA Interpret Platform to Transform Biological Data Analysis - StockTitan
Qiagen (NYSE:QGEN) Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Qiagen (NYSE:QGEN) Given "Buy" Rating at Jefferies Financial Group - MarketBeat
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly - Simply Wall St
Point72 Asset Management L.P. Trims Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
Janus Henderson Group PLC Reduces Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements - MSN
Qiagen shares get Buy rating, $54 target from Jefferies By Investing.com - Investing.com Canada
Qiagen shares get Buy rating, $54 target from Jefferies - Investing.com
Jefferies Starts Qiagen NV (QGEN) at Buy - StreetInsider.com
QIAGEN Wins FDA Clearance of QIAstat-Dx Meningitis/Encephalitis Panel - MPO-mag
Quantinno Capital Management LP Has $3.56 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
25,658 Shares in Qiagen (NYSE:QGEN) Acquired by Verition Fund Management LLC - MarketBeat
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound? - MSN
Fmr LLC Raises Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now? - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 321,182 Shares of Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation - Silicon Canals
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Edgestream Partners L.P. Reduces Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Parkman Healthcare Partners LLC Decreases Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
219,245 Shares in Qiagen (NYSE:QGEN) Purchased by Holocene Advisors LP - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Point72 Hong Kong Ltd Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Stock Holdings Increased by Public Sector Pension Investment Board - MarketBeat
Qiagen (NYSE:QGEN) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
FY2024 Earnings Forecast for Qiagen Issued By Zacks Research - MarketBeat
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Martingale Asset Management L P Decreases Position in Qiagen (NYSE:QGEN) - MarketBeat
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site - Yahoo Finance
QIAGEN announces new site in Barcelona for QIAstat-Dx operations - Medical Device Network
QIAGEN introduces new custom tools for microbial analysis - Yahoo Finance
Quantbot Technologies LP Has $3.31 Million Stake in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Expands Diagnostic Operations with New 8,000sqm Barcelona Facility for QIAstat-Dx | QGEN Stock News - StockTitan
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis - GlobeNewswire
QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients - br.ADVFN.com
Qiagen (NYSE:QGEN) Shares Sold by Citigroup Inc. - MarketBeat
QIAGEN Launches Groundbreaking Custom Microbial Analysis Tools for Digital PCR & NGS - StockTitan
QIAGEN Gains FDA Clearance for Latest Respiratory Mini-Panel Test - MPO-mag
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Qiagen Nv Azioni (QGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):